Early Detection
Surgery offers pancreatic cancer patients the best chance for long-term survival, yet currently less than 20% of patients are eligible upon diagnosis. Unfortunately, the majority of pancreatic cancers are identified after the disease has metastasized, or spread to other organs, making treatment more challenging.
But Lustgarten-supported researchers are always up for a challenge. We are committed to funding the world’s best earlier detection research, giving patients and their families more help—and more hope—than ever before.
-
CancerSEEK
CancerSEEK, developed by Lustgarten-funded researcher Dr. Bert Vogelstein and his team at Johns Hopkins Kimmel Cancer Center, has been proven to detect the early presence of pancreatic and nine other cancers.
-
FELIX
Leveraging artificial intelligence, the FELIX program uses data from thousands of scans to teach computers to detect tumors small enough to be missed by even the most experienced radiologists.
-
GENERATE
The GENERATE Study is designed to improve genetic testing and cancer prevention in family members of pancreatic cancer patients.
